Lan Xu
About
In The Last Decade
Lan Xu
17 papers receiving 546 citations
Peers
Comparison fields: 5 of 83
- Oncology 306
- Molecular Biology 243
- Radiology, Nuclear Medicine and Imaging 227
- Immunology 70
- Pulmonary and Respiratory Medicine 34
Countries citing papers authored by Lan Xu
This map shows the geographic impact of Lan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Xu more than expected).
Fields of papers citing papers by Lan Xu
This network shows the impact of papers produced by Lan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Xu. The network helps show where Lan Xu may publish in the future.
Co-authorship network of co-authors of Lan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Lan Xu. A scholar is included among the top collaborators of Lan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Xu. Lan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 18 | |
| 10 | 292 | |
| 11 | 8 | |
| 12 | 45 | |
| 13 | 5 | |
| 14 | 67 | |
| 15 | 96 | |
| 16 | Quality Prediction Model by Using PSO-BP Neural Network | 1 |
| 17 | [Genetic susceptibility of single nucleotide polymorphism in MGMT to non-Hodgkin lymphoma]. | 7 |
| 18 | [Preparation and characterization of monoclonal antibodies against CMTM7]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.